Literature DB >> 3144698

Negative regulation of c-abl tyrosine kinase by its variable N-terminal amino acids.

J Y Wang1.   

Abstract

Activation of the oncogenic potential of c-abl proto-oncogene has been correlated with the activation of its tyrosine kinase activity. The oncogenes derived from c-abl, e.g., gag/v-abl in Abelson murine leukemia virus or bcr/abl in chronic myelogenous leukemia, lack N-terminal coding sequences of the normal c-abl gene. In mouse and human cells, two sets of N-terminal amino acids encoded by 5'-variable exons are found in c-abl proteins. To assess the importance of N-terminal deletion in the activation of c-abl tyrosine kinase, a full length or an N-terminal deleted c-abl protein was expressed in bacteria and in monkey COS cells. Measurements of the autokinase activity of these two c-abl proteins showed that deletion of the N-terminal amino acids led to a three to five fold increase of the c-abl tyrosine kinase activity. Thus, the N-terminal deletion is important in the activation of c-abl proto-oncogene.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3144698

Source DB:  PubMed          Journal:  Oncogene Res        ISSN: 0890-6467


  7 in total

1.  Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins.

Authors:  J R McWhirter; J Y Wang
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

2.  Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitor.

Authors:  A M Pendergast; A J Muller; M H Havlik; R Clark; F McCormick; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

3.  Conservation of function of Drosophila melanogaster abl and murine v-abl proteins in transformation of mammalian cells.

Authors:  G D Holland; M J Henkemeyer; D A Kaehler; F M Hoffmann; R Risser
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

4.  Enteropathogenic Escherichia coli use redundant tyrosine kinases to form actin pedestals.

Authors:  Alyson Swimm; Bettina Bommarius; Yue Li; David Cheng; Patrick Reeves; Melanie Sherman; Darren Veach; William Bornmann; Daniel Kalman
Journal:  Mol Biol Cell       Date:  2004-05-21       Impact factor: 4.138

5.  Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential.

Authors:  W M Franz; P Berger; J Y Wang
Journal:  EMBO J       Date:  1989-01       Impact factor: 11.598

6.  Hormone-conditional transformation by fusion proteins of c-Abl and its transforming variants.

Authors:  P Jackson; D Baltimore; D Picard
Journal:  EMBO J       Date:  1993-07       Impact factor: 11.598

7.  An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias.

Authors:  J R McWhirter; J Y Wang
Journal:  EMBO J       Date:  1993-04       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.